Kayne Anderson Rudnick Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-300
| Closed | -$4.43K | – | 1028 |
|
|
2024
Q1 | $4.43K | Hold |
300
| – | – | ﹤0.01% | 685 |
|
|
2023
Q4 | $4.02K | Hold |
300
| – | – | ﹤0.01% | 689 |
|
|
2023
Q3 | $3.7K | Hold |
300
| – | – | ﹤0.01% | 641 |
|
|
2023
Q2 | $3.69K | Hold |
300
| – | – | ﹤0.01% | 641 |
|
|
2023
Q1 | $3.69K | Hold |
300
| – | – | ﹤0.01% | 607 |
|
|
2022
Q4 | $3.44K | Hold |
300
| – | – | ﹤0.01% | 624 |
|
|
2022
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 638 |
|
|
2022
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 586 |
|
|
2022
Q1 | $2K | Buy |
+300
| New | +$2K | ﹤0.01% | 611 |
|